https://www.marketscreener.com/quote/stock/DIAMYD-MEDICAL-AB-39435154/news/In-Depth-Analysis-of-Diamyd-Medical-AB-s-Phase-II-Trial-Further-Supports-Value-of-Presented-Insulin-45803632/?utm_source=telegram&utm_medium=social&utm_campaign=share